← Leaderboards
Richard Schwartz
National Institute Of Allergy And Infectious Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute Of Allergy And Infectious Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Production”
- Eric S Lander · Whitehead Institute For Biomedical Res$568,626,051
- Bambra Strokes · Ppd Development Lp$526,656,217
- Richard A Gibbs · Baylor College Of Medicine$521,766,399
- Tracy L Nolen · Research Triangle Institute$451,761,218
- Sonia M Thomas · Research Triangle Institute$451,761,218
- David Heimbrook · Leidos Biomedical Research, Inc.$332,994,970
Research focus
ProductionVaccinesVaccine ProductionProgramsClinical TrialsPlantsLaboratoriesClinicClinical MaterialNational Institute Of Allergy And Infectious DiseaseContractsPlacebosSafety StudyPreclinical SafetyManufacturing ProcessDesignImmune ResponseLaboratory StudyVector VaccinePreclinical StudyAdenovirus VectorSerotypingDna VaccinesInfluenza Virus Vaccine
Grant awards (69)
Establishment of a Vaccine Pilot Plant$16,560,276
ZIB · FY2016 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$11,507,499
ZIB · FY2016 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$10,159,913
ZIB · FY2016 · AI · contact PI
Development/production of universal influenza vaccines$7,764,128
ZIB · FY2016 · AI · contact PI
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)$3,132,917
ZIA · FY2016 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,166,079
ZIB · FY2016 · AI · contact PI
Development and Production of alphavirus vaccines$901,428
ZIB · FY2016 · AI · contact PI
Development/production of universal influenza vaccines$15,099,170
ZIB · FY2015 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$8,445,410
ZIB · FY2015 · AI · contact PI
Establishment of a Vaccine Pilot Plant$6,292,469
ZIB · FY2015 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,166,079
ZIB · FY2015 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$2,159,913
ZIB · FY2015 · AI · contact PI
Development and Production of alphavirus vaccines$601,428
ZIB · FY2015 · AI · contact PI
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)$132,917
ZIA · FY2015 · AI · contact PI
Development/production of universal influenza vaccines$11,743,293
ZIB · FY2014 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$7,055,396
ZIB · FY2014 · AI · contact PI
Establishment of a Vaccine Pilot Plant$6,281,133
ZIB · FY2014 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,166,079
ZIB · FY2014 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$2,159,913
ZIB · FY2014 · AI · contact PI
Development and Production of alphavirus vaccines$2,101,428
ZIB · FY2014 · AI · contact PI
Development/production of universal influenza vaccines$13,453,832
ZIB · FY2013 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibodies$7,055,396
ZIB · FY2013 · AI · contact PI
Establishment of a Vaccine Pilot Plant$6,281,133
ZIB · FY2013 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,166,079
ZIB · FY2013 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$2,159,913
ZIB · FY2013 · AI · contact PI
Development and Production of alphavirus vaccines$1,829,600
ZIB · FY2013 · AI · contact PI
Development/production of universal influenza vaccines$13,453,832
ZIB · FY2012 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibody (VRC01)$7,055,396
ZIB · FY2012 · AI · contact PI
Establishment of a Vaccine Pilot Plant$6,376,856
ZIB · FY2012 · AI · contact PI
Development And Production Of Filovirus DNA Plasmid Vaccines$2,166,079
ZIB · FY2012 · AI · contact PI
Development/production of seasonal, pandemic and universa influenza DNA vaccines$2,166,079
ZIB · FY2012 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,166,079
ZIB · FY2012 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$2,159,913
ZIB · FY2012 · AI · contact PI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine$2,149,913
ZIB · FY2012 · AI · contact PI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine$2,149,913
ZIB · FY2012 · AI · contact PI
Development and Production of Chikungunya vaccines$1,829,600
ZIB · FY2012 · AI · contact PI
HIV LCMV vaccines$565,994
ZIB · FY2012 · AI · contact PI
Establishment of a Vaccine Pilot Plant$27,372,683
ZIB · FY2011 · AI · contact PI
Development/production of universal influenza vaccines$1,829,600
ZIB · FY2011 · AI · contact PI
Development and Production of Chikungunya vaccines$1,829,600
ZIB · FY2011 · AI · contact PI
Production of a Broadly Neutralizing HIV Antibody (VRC01)$1,755,395
ZIB · FY2011 · AI · contact PI
HIV LCMV vaccines$1,565,994
ZIB · FY2011 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$1,159,913
ZIB · FY2011 · AI · contact PI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine$1,149,913
ZIB · FY2011 · AI · contact PI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine$1,149,913
ZIB · FY2011 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$816,079
ZIB · FY2011 · AI · contact PI
Development And Production Of Filovirus DNA Plasmid Vaccines$816,079
ZIB · FY2011 · AI · contact PI
Development/production of seasonal, pandemic and universa influenza DNA vaccines$816,079
ZIB · FY2011 · AI · contact PI
Establishment of a Vaccine Pilot Plant$28,893,733
ZIB · FY2010 · AI · contact PI
ARRA: Process Development and Manufacture of Universal Influenza Vaccine$13,400,000
ZIB · FY2010 · AI · contact PI
ARRA: H1N1 and Other ARRA Equipment$3,314,695
ZIB · FY2010 · AI · contact PI
HIV LCMV vaccines$2,040,198
ZIB · FY2010 · AI · contact PI
Development and Production of Chikungunya vaccines$1,829,600
ZIB · FY2010 · AI · contact PI
Development/production of universal influenza vaccines$1,829,600
ZIB · FY2010 · AI · contact PI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine$1,224,119
ZIB · FY2010 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$1,224,119
ZIB · FY2010 · AI · contact PI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine$1,224,119
ZIB · FY2010 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$816,079
ZIB · FY2010 · AI · contact PI
Development/production of seasonal and pandemic influenza DNA vaccines$816,079
ZIB · FY2010 · AI · contact PI
Development And Production Of Filovirus DNA Plasmid Vaccines$816,079
ZIB · FY2010 · AI · contact PI
Establishment of a Vaccine Pilot Plant$28,794,266
ZIB · FY2009 · AI · contact PI
Development/Production-Alternative Serotype HIV Recombinant Adenoviral Vaccine$5,862,877
ZIB · FY2009 · AI · contact PI
Development And Production Of A Multiclade HIV-1 DNA Plasmid Vaccine$4,212,877
ZIB · FY2009 · AI · contact PI
Development Of A Multicomponent HIV-1 Recombinant Adenoviral Vector Vaccine$4,212,877
ZIB · FY2009 · AI · contact PI
Development/production of seasonal and pandemic influenza DNA vaccines$2,233,172
ZIB · FY2009 · AI · contact PI
Production of Alternate Adenovector Filovirus Vaccines$2,233,172
ZIB · FY2009 · AI · contact PI
Development And Production Of Filovirus DNA Plasmid Vaccines$2,133,173
ZIB · FY2009 · AI · contact PI
HIV LCMV vaccines$1,650,000
ZIB · FY2009 · AI · contact PI
Development and Production of Chikungunya vaccines$100,000
ZIB · FY2009 · AI · contact PI